4.6 Review

Neuropsychiatric Symptoms in Parkinson's Disease

期刊

MOVEMENT DISORDERS
卷 24, 期 15, 页码 2175-2186

出版社

WILEY
DOI: 10.1002/mds.22589

关键词

apathy; hallucinations; depression; anxiety; Parkinson's disease

资金

  1. Novartis Pharmaceuticals
  2. GE Health
  3. Boehringer Ingelheim
  4. Osmotica Pharmaceuticals

向作者/读者索取更多资源

Neuropsychiatric symptoms are common in Parkinson's disease, even at the earliest stages. and have important consequences for quality of life and daily functioning, are associated with increased carer burden and increased risk for nursing home admission. In addition to cognitive impairment, a wide range of neuropsychiatric symptoms have been reported. In this article, the epidemiology, clinical course, disagnosis, and management of some of the most common neuropsychiatric symptoms in PD are discussed: depression, anxiety, apathy, fatigue, and psychotic symptoms. Although much is known regarding the prevalence and course of these symptoms, the empirical evidence for how to manage these symptoms is limited at best. There is thus an urgent need for systematic studies for the pharmacological and non-pharmacological management of these symptoms. (C) 2009 Movement Disorder Society

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据